Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis

Acta Oncologica

Volumn 45, Issue 6, 2006, Pages 643-661

  Ericsson, Christer ^a   Franzén, Bo ^b   Nistér, Monica ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

BLOOD ANALYSIS; CONTAMINATION; CRYOPRESERVATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; FREEZING; GEL ELECTROPHORESIS; HEALTH CARE FACILITY; HUMAN; ISOTOPE LABELING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SPECTROMETRY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TISSUE PRESERVATION;

EID: 33748636268     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600818047     Document Type: Review

References (95)

1. Qualman SJ, France M, Grizzle WE, LiVolsi VA, Moskaluk CA, Ramirez NC, et al. Establishing a tumour bank: Banking, informatics and ethics. Br J Cancer 2004;90:1115-9.
2. Vortmeyer AO, Weil RJ, Zhuang Z. Proteomic applications for differential diagnosis of histologically identical tumors. Neurology 2003;61:1626-7.
3. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2005.
4. Anderson NL, Anderson NG. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-67.
5. Craven RA, Banks RE. Use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis. Methods Enzymol 2002;356:33-49.
6. Franzen B, Linder S, Okuzawa K, Kato H, Auer G. Nonenzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1993; 14:1045-53.
7. Omenn GS. The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 2004;4:1235-40.
8. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005;5:3226-45.
9. Banks RE, Stanley AJ, Cairns DA, Barret JH, Clarke PC, Thompson D, et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 2005;51:1637-49.
10. Hulmes JD, Bethea D, Ho K, Huang S-P, Ricci DL, Opiteck GJ, et al. An investigation of plasma collection, stabilization, and storage procedures for proteomic analysis of clinical samples. Clin Proteomics J 2004;1:17-31.
11. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262-77.
12. Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Mohring T, et al. Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display. Proteomics 2005;5:3414-22.
13. Muller A, MacCallum RM, Sternberg MJE. Structural characterization of the human proteome. Genome Research 2002;12:1625-41.
14. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, et al. The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003;3:1345-64.
15. Shmueli O, Horn-Saban S, Chalifa-Caspi V, Shmoish M, Ophir R, Benjamin-Rodrig H, et al. GeneNote: Whole genome expression profiles in normal human tissues. C R Biol 2003;326:1067-72.
16. Su AI, Cooke MP, Ching KA, Hakak Y,Walker JR, Wiltshire T, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002;99:4465-70.
17. Righetti PG, Castagna A, Herbert B, Reymond F, Rossier JS. Prefractionation techniques in proteome analysis. Proteomics 2003;3:1397-407.
18. Perrot M, Sagliocco F, Mini T, Monribot C, Schneider U, Shevchenko A, et al. Two-dimensional gel protein database of Saccharomyces cerevisiae (update 1999). Electrophoresis 1999;20:2280-98.
19. rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;19:242-7.
20. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: The yeast proteome. J Proteome Res 2003;2:43-50.
21. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N, et al. Global analysis of protein expression in yeast. Nature 2003;425(6959):737-41.
22. Jacobs JM, Mottaz HM, Yu LR, Anderson DJ, Moore RJ, Chen WN, et al. Multidimensional proteome analysis of human mammary epithelial cells. J Proteome Res 2004;3:68-75.
23. Humphery-Smith I. A human proteome project with a beginning and an end. Proteomics 2004;4:2519-21.
24. Nilsson P, Paavilainen L, Larsson K, Odling J, Sundberg M, Andersson AC, et al. Towards a human proteome atlas: High-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 2005.
25. Uhlen M, Ponten F. Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 2005;4:384-93.
26. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J, et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 2002;20:301-5.
27. Salomon AR, Ficarro SB, Brill LM, Brinker A, Phung QT, Ericson C, et al. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci USA 2003;100:443-8.
28. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002;298(5600):1912-34.
29. Wang WQ, Sun JP, Zhang ZY. An overview of the protein tyrosine phosphatase superfamily. Curr Top Med Chem 2003;3:739-48.
30. McCluskey A, Sim AT, Sakoff JA. Serine-threonine protein phosphatase inhibitors: Development of potential therapeutic strategies. J Med Chem 2002;45:1151-75.
31. Honkanen RE, Golden T. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? Curr Med Chem 2002;9:2055-75.
32. Qian WJ, Goshe MB, Camp DG, 2nd, Yu LR, Tang K, Smith RD. Phosphoprotein isotope-coded solid-phase tag approach for enrichment and quantitative analysis of phosphopeptides from complex mixtures. Anal Chem 2003;75:5441-50.
33. Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T, Schulenberg B, et al. Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology. Proteomics 2003;3:1128-44.
34. Guy GR, Philip R, Tan YH. Analysis of cellular phosphoproteins by two-dimensional gel electrophoresis: Applications for cell signaling in normal and cancer cells. Electrophoresis 1994;15:417-40.
35. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003;3:2085-90.
36. Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005; 51:1933-45.
37. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, et al. Toward a human blood serum proteome: Analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 2002;1:947-55.
38. Cho SY, Lee EY, Lee JS, Kim HY, Park JM, Kwon MS, et al. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics 2005;5:3386-96.
39. Tang HY, Ali-Khan N, Echan LA, Levenkova N, Rux JJ, Speicher DW. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 2005;5:3329-42.
40. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res 2004;3:235-44.
41. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M, et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res 2002;62:6740-9.
42. Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576-8.
43. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
44. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA, et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 2003;100:12343-8.
45. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359(9306):572-7.
46. Diamandis EP. Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems. J Natl Cancer Inst 2004;96:353-6.
47. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C, et al. Human and mouse proteases: A comparative genomic approach. Nature Rev Gen 2003;4:544-58.
48. Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, et al. Cell death: Apoptosis versus necrosis (review). Int J Oncol 2002;21:165-70.
49. Olivieri E, Herbert B, Righetti PG. The effect of protease inhibitors on the two-dimensional electrophoresis pattern of red blood cell membranes. Electrophoresis 2001; 22:560-5.
50. Mykles DL. Proteinase families and their inhibitors. Methods Cell Biol 2001;66:247-87.
51. Rivard AL, Gallegos RP, Bianco RW, Liao K. The basic science aspect of donor heart preservation: A review. J Extra-Corp Technol 2004;269-74.
52. Cosi C, Marien M. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): Prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res 1998;809:58-67.
53. Ansari KA, Rand A, Hendrickson H, Bentley MD. Qualitative and quantitative studies on human myelin basic protein in situ with respect to time interval between death and autopsy. J Neuropathol Exp Neurol 1976;35:180-90.
54. Berlet HH, Volk B. Studies of human myelin proteins during old age. Mech Ageing Dev 1980;14:211-22.
55. Goggins M, Scott JM, Weir DG. Regional differences in protein carboxymethylation in post-mortem human brain. Clin Sci (Lond) 1998;94:677-85.
56. Naser NA, Naser SA. Clinical Chemistry Laboratory Manual 1998: Mosby Inc.
57. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5:845-56.
58. Mustard JF, Kinlough-Rathbone RL, Packham MA. Isolation of human platelets from plasma by centrifugation and washing. Methods Enzymol 1989;169:3-11.
59. Lewis MR, Callas PW, Jenny NS, Tracy RP. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 2001;86:1495-500.
60. Chaurand P, Schwartz SA, Billheimer D, Xu BJ, Crecelius A, Caprioli R. Integrating histology and imaging mass spectrometry. Anal Chem 2004;76:1145-55.
61. Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, Toms SA, et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 2005;65:7674-81.
62. Schwartz SA,Weil RJ, Johnson MD, Toms SA, Caprioli RM. Protein profiling in brain tumors using mass spectrometry: Feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 2004;10:981-7.
63. Dill KA. Dominant forces in protein folding. Biochemistry 1990;29:7133-55.
64. Kauzmann W. Some factors in the interpretation of protein denaturation. Adv Protein Chem 1959;14:1-63.
65. Scopes RK. Making an extract, in protein purification: Principles and practice. 1987.
66. Dignam JD. Preparation of extracts from higher eukaryotes. Methods Enzymol 1990;182:194-203.
67. Bollag DM, Edelstein SJ. Protein Methods. New York, Chichester, Brisbane, Toronto, Singapore: Wiley-Liss; 1991.
68. Deutscher MP. Maintaining protein stability. Methods Enzymol 1990;182:83-9.
69. Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci USA 2003;100:9330-5.
70. Harder A, Wildgruber R, Nawrocki A, Fey SJ, Larsen PM, Gorg A. Comparison of yeast cell protein solubilization procedures for two-dimensional electrophoresis. Electrophoresis 1999;20:826-9.
71. Newcombe J, Eriksson B, Ottervald J, Yang Y, Franzen B. Extraction and proteomic analysis of proteins from normal and multiple sclerosis postmortem brain. J Chromatogr B Analyt Technol Biomed Life Sci 2005;815:191-202.
72. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227(259):680-5.
73. Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol 1973;80:575-99.
74. Steinberg TH, Jones LJ, Haugland RP, Singer VL. SYPRO orange and SYPRO red protein gel stains: One-step fluorescent staining of denaturing gels for detection of nanogram levels of protein. Anal Biochem 1996;239:223-37.
75. Steinberg TH, Haugland RP, Singer VL. Applications of SYPRO orange and SYPRO red protein gel stains. Anal Biochem 1996;239:238-45.
76. Mackintosh JA, Choi HY, Bae SH, Veal DA, Bell PJ, Ferrari BC, et al. A fluorescent natural product for ultra sensitive detection of proteins in one-dimensional and two-dimensional gel electrophoresis. Proteomics 2003;3:2273-88.
77. Steinberg TH, Pretty On Top K, Berggren KN, Kemper C, Jones L, Diwu Z, et al. Rapid and simple single nanogram detection of glycoproteins in polyacrylamide gels and on electroblots. Proteomics 2001;1:841-55.
78. Burnette WN. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981;112:195-203.
79. Bjellqvist B, Ek K, Righetti PG, Gianazza E, Gorg A, Westermeier R, et al. Isoelectric focusing in immobilized pH gradients: Principle, methodology and some applications. J Biochem Biophys Methods 1982;6:317-39.
80. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-21.
81. O'Farrell PZ, Goodman HM, O'Farrell PH. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977;12:1133-41.
82. Sabounchi-Schutt F, Astrom J, Olsson I, Eklund A, Grunewald J, Bjellqvist B. An immobiline DryStrip application method enabling high-capacity two-dimensional gel electrophoresis. Electrophoresis 2000;21:3649-56.
83. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-304.
84. Michaud GA, Salcius M, Zhou F, Bangham R, Bonin J, Guo H, et al. Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol 2003;21:1509-12.
85. Chalmers MJ, Quinn JP, Blakney GT, Emmett MR, Mischak H, Gaskell SJ, et al. Liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometric characterization of protein kinase C phosphorylation. J Proteome Res 2003;2:373-82.
86. Goshe MB, Veenstra TD, Panisko EA, Conrads TP, Angell NH, Smith RD. Phosphoprotein isotope-coded affinity tags: Application to the enrichment and identification of lowabundance phosphoproteins. Anal Chem 2002;74:607-16.
87. Zhou H, Watts JD, Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat Biotechnol 2001;19:375-8.
88. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, et al. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003;3:36-44.
89. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003; 426(6966):570-4.
90. Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 2003;21:315-8.
91. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999;17:994-9.
92. Gygi SP, Rist B, Griffin TJ, Eng J, Aebersold R. Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J Proteome Res 2002;1:47-54.
93. Ranish JA, Yi EC, Leslie DM, Purvine SO, Goodlett DR, Eng J, et al. The study of macromolecular complexes by quantitative proteomics. Nat Genet 2003;33:349-55.
94. Wingren C, Ingvarsson J, Lindstedt M, Borrebaeck CA. Recombinant antibody microarrays-a viable option? Nat Biotechnol 2003;21:223.
95. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci USA 2003;100:6940-5.